VRTX Vertex Pharmaceuticals PE ratio, current and historical analysis

The current PE ratio of VRTX cannot be calculated, as the latest EPS of -$2.08 is negative. Vertex Pharmaceuticals's last PE ratio on record was 26.83 in March 2024.

VRTX PE ratio history

How has VRTX's PE ratio performed in the past

The mean historical PE ratio of Vertex Pharmaceuticals over the last eight years is 53.28. Analyzing the last eight years, VRTX's PE ratio reached its highest point in the Sep 2017 quarter at 190.05, with a price of $152.04 and an EPS of $0.8. The Dec 2018 quarter saw the lowest point at 20.11, with a price of $165.71 and an EPS of $8.24.

Today
N/A
Average
53.28
Median
26.27
Minimum
20.11
Maximum
190.05

Vertex Pharmaceuticals PE ratio by year

Maximum annual increase: 137.74% in 2019

Maximum annual decrease: -85.78% in 2018

Year PE ratio PE change Price EPS
2024 N/A N/A $402.7 -$2.08
2023 28.96 30.04% $406.89 $14.05
2022 22.27 -7.82% $288.78 $12.97
2021 24.16 6.71% $219.6 $9.09
2020 22.64 -52.65% $236.34 $10.44
2019 47.81 137.74% $218.95 $4.58
2018 20.11 -85.78% $165.71 $8.24
2017 141.38 N/A $149.86 $1.06
2016 N/A N/A $73.67 -$0.46
2015 N/A N/A $125.83 -$2.31
2014 N/A N/A $118.8 -$3.14
2013 N/A N/A $74.3 -$1.98
2012 N/A N/A $41.9 -$0.5
2011 237.21 N/A $33.21 $0.14
2010 N/A N/A $35.03 -$3.77

Vertex Pharmaceuticals PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Dec 2024 N/A N/A $402.7 -$2.08
Sep 2024 N/A N/A $465.08 -$1.85
Jun 2024 N/A N/A $468.72 -$1.89
Mar 2024 26.83 -7.35% $418.01 $15.58
Dec 2023 28.96 12.16% $406.89 $14.05
Sep 2023 25.82 -3.94% $347.74 $13.47
Jun 2023 26.88 8.43% $351.91 $13.09
Mar 2023 24.79 11.32% $315.07 $12.71
Dec 2022 22.27 -1.55% $288.78 $12.97
Sep 2022 22.62 0.09% $289.54 $12.8
Jun 2022 22.6 -17.22% $281.79 $12.47
Mar 2022 27.3 13% $260.97 $9.56
Dec 2021 24.16 12.16% $219.6 $9.09
Sep 2021 21.54 -17.94% $181.39 $8.42
Jun 2021 26.25 29.95% $201.63 $7.68

VRTX average PE ratio chart

What is the average PE ratio of VRTX for the past years
3-year avg
25.1
5-year avg
25.33
10-year avg
53.28
15-year avg
58.44

VRTX PE vs peers

What is VRTX's PE ratio compared to its peers
Stock name PE ratio Market cap
MRK Merck & Co Inc 12.81 $218.75B
JNJ Johnson & Johnson 26.6 $374.05B
ABBV AbbVie Inc 85.5 $362.23B
GILD Gilead Sciences Inc 294.45 $139.34B
BMY Bristol Myers Squibb Co N/A $120.95B
ENTA Enanta Pharmaceuticals Inc N/A $113.06M
VRTX Vertex Pharmaceuticals Inc N/A $124.16B

Frequently asked questions

What is Vertex Pharmaceuticals's PE ratio?

The current price to earnings ratio of VRTX cannot be determined, as its EPS of -$2.08 is negative.

What is the 3-year average PE ratio for Vertex Pharmaceuticals (VRTX)?

Over the last 3 years, the average PE ratio for VRTX stock is 25.1.

What is the 5-year average PE ratio for Vertex Pharmaceuticals (VRTX)?

Over the last 5 years, the average PE ratio for VRTX stock is 25.33.

What is the highest PE ratio for VRTX?

The highest quarterly PE ratio in the last eight years has been 190.05 and it was in the Sep 2017 quarter.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.